Recipharm AB acquires Abbott Manufacturing Site in Spain
Recipharm AB announced that they have acquired Abbott’s (formerly Solvay Pharmaceuticals) manufacturing site in Parets, close to Barcelona, Spain for an undisclosed sum. Parets produces solid dose, sterile ointments, oral liquids, aerosols and topical products. The site, which has benefited from high levels of investment in recent years, is well suited to the flexible requirements of a contract manufacturing operation, already servicing a number of companies. The newly acquired business will be called Recipharm Parets SL.
This move further enhances Recipharm’s capabilities, providing a base in the strategically important Spanish market, whilst bringing new customer relationships into the Recipharm Group. It also reinforces Recipharm’s strategic goal to become one of the world’s leading Contract Development and Manufacturing Organisations (CDMO), offering a ‘one-stop shop’ for the development and manufacturing of both small and large molecule biopharmaceuticals.
Recipharm will continue to produce all Abbott products currently manufactured at the site. Recipharm also intends to retain all existing employees.
Other news from the department manufacturing
